Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: A polysomnographic study

Sleep Medicine

Volumn 10, Issue 6, 2009, Pages 616-620

  Staner, L ^a   Eriksson, M ^b   Cornette, F ^a   Santoro, F ^a   Muscat, N ^b   Luthinger, R ^a   Roth, T ^c  

^a FORENAP   (France)

^b Orexo AB   (Sweden)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

Latency; Polysomnography; Post nap model; Sleep initiation; Transient insomnia; Zolpidem

Indexed keywords

OX 22; UNCLASSIFIED DRUG; ZOLPIDEM TARTRATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HUMAN; INSOMNIA; LATENT PERIOD; MALE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP; SOMNOLENCE; VOLUNTEER; WAKEFULNESS;

ADMINISTRATION, ORAL; ADMINISTRATION, SUBLINGUAL; ADULT; ANALYSIS OF VARIANCE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; POLYSOMNOGRAPHY; PYRIDINES; QUESTIONNAIRES; REACTION TIME; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67349208203     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2008.06.008     Document Type: Article

References (34)

1. Doghramji K. The epidemiology and diagnosis of insomnia. Am J Manage Care 12 8 (2006) S214-S220
2. Leger D., and Poursain B. An international survey of insomnia: under-recognition and under-treatment of a polysymptomatic condition. Curr Med Res Opin 21 11 (2005) 1785-1792
3. Roth T., and Drake C. Evolution of insomnia: current status and future direction. Sleep Med 5 Suppl. 1 (2004) S23-S30
4. Bixler E.O., Kales A., Soldatos C.R., Kales J.D., and Healy S. Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry 136 (1979) 1257-1262
5. Vermeeren A. Residual effects of hypnotics. Epidemiology and clinical implications. CNS Drugs 18 5 (2004) 297-328
6. Holm K.J., and Goa K.L. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs 59 4 (2000) 865-889
7. Dijk D.J., Beersma D.G., Daan S., and van den Hoofdakker R.H. Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleep stages and EEG power spectra. Eur J Pharmacol 171 (1989) 207-218
8. Mathias S., Steiger A., and Lancel M. The GABAa agonist gaboxadol improves the quality of post-nap sleep. Psychopharmacology 157 (2001) 299-304
9. Karacan I., Williams R.L., Finley W.W., and Hursch C.J. The effects of naps on nocturnal sleep: influence on the need for stage-1 REM and stage 4 sleep. Biol Psychiatry 2 (1970) 391-399
10. Feinberg I., March J.D., Floyd T.C., Jimison R., Bossom-Demitrack L., and Katz P.H. Homeostatic changes during post-nap sleep maintain baseline level of delta EEG. EEG Clin Neurophysiol 61 (1985) 134-137
11. Werth E., Dijk D.J., Achermann P., and Borbély A.A. Dynamics of the sleep EEG after an early evening nap: Experimental data and simulations. Am J Physiol 27 (1996) R501-R510
12. Cornette F, Metzger D, Calvi-Gries F, Bouyoult K, Muzet A, Luthringer R, et al. Post-nap or first-night effect as model for transient insomnia: a comparison of visual and spectral analysis of sleep EEG. XVIII ESRS Congress, Innsbruck, Austria, September 12-16th; 2006.
13. Youngstedt S.D. Ceiling and floor effects in sleep research. Sleep Med Rev 7 (2003) 351-365
14. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., and Kupfer D.J. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28 (1989) 193-213
15. Horne J.A., and Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol 4 2 (1976) 97-110
16. Toussaint M., Schaltenbrand N., Paiva T., Pollmacher T., Pflieger C., Luthringer R., et al. An architecture for EEG signal processing and interpretation during sleep (ESPIS). Comput Methods Programs Biomed 45 (1994) 55-60
17. Rechtschaffen A, Kales AA. A manual of standardized terminology techniques and scoring system for sleep stage of human subjects. Washington, DC: National Institute of Health, publication 204. Government Printing Officer; 1968.
18. Staner L., Duval F., Calvi-Gries F., et al. Morning and evening TSH response to TRH and sleep EEG in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 25 (2001) 543-547
19. Parrot A.C., and Hindmarch I. The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations. A review. Psychopharmacology 71 (1980) 173-179
20. Bond A., and Lader M. The use of analogue scales in rating subjective feelings. Br J Med Psychol 47 (1974) 211-218
21. Smith J.M., and Misiak H. Critical Flicker Frequency (CFF) and psychotropic drugs in normal human subjects-a review. Psychopharmacology 47 (1976) 175-182
22. Hindmarch I. Psychomotor function and psychoactive drugs. Br J Clin Pharmacol 10 3 (1980) 189-209
23. Wechsler D. Echelle d'intelligence de Wechsler pour adultes, forme révisée (WAISR III) (1997), Centre de Psychologie Appliquée, Paris
24. Caillé G., Spénard J., Lacasse Y., and Brennan J. Pharmacokinetics of two lorazepam formulations, oral and sublingual, after multiple doses. Biopharm Drug Dispos 4 (1983) 31-42
25. Fujii J., Inotsume N., and Nakano M. Relative bioavailability of midazolam following sublingual versus oral administration in healthy volunteers. J Pharmacobiodyn 11 (1988) 206-209
26. Kanno O., Sasaki T., Watanabe H., Takazawa S., Nakagome K., Nakajima T., et al. Comparison of the effects of zolpidem and triazolam on nocturnal sleep and sleep latency in the morning: a cross-over study in healthy young volunteers. Prog Neuropsychopharmacol Biol Psychiatry 24 (2000) 897-910
27. Deacon S., Staner L., Staner C., Letgers A., Loft H., and Lundahl J. Effect of a short-term treatment with gaboxadol on sleep maintenance and in patients with primary insomnia. Sleep 30 (2007) 281-297
28. Lundahl J., Staner L., Staner C., Loft H., and Deacon S. Short-term treatment with gaboxadol improves sleep maintenance and enhances slow wave sleep in adult patients with primary insomnia. Psychopharmacology 195 (2007) 139-146
29. Cluydts R., De Roeck J., Cosysns P., and Lacante P. Antagonising the effects of experimentally induced sleep disturbance in healthy volunteers by lormetazepam and zolpidem. J Clin Psychopharmacol 15 (1995) 132-137
30. Erman M.K., Erwin C.W., Gengo F.M., Jamieson A.O., Lemmi H., Mahowald M.W., et al. Comparative efficacy of zolpidem and temazepam in transient insomnia. Hum Psychopharmacol 16 (2001) 169-176
31. Walsh J.K., Schweitzer P.K., Sugerman J.L., and Muehlbach M.J. Transient insomnia associated with a 3-hour phase advance of sleep time and treatment with zolpidem. J Clin Psychopharmacol 10 (1990) 184-189
32. Toussaint M., Luthringer R., Schaltenbrand N., Carelli G., Lainey E., Jacqmin A., et al. First-night effect in normal subjects and psychiatric inpatients. Sleep 18 (1995) 463-469
33. Le Bon O., Staner L., Hoffmann G., Dramaix M., San Sebastian I., Murphy J.R., et al. The first night effect may last more than one night. J Psychiatry Res 35 (2001) 165-172
34. Rosenzweig P., Brohier S., and Zipfel A. The placebo effect in healthy volunteers: influence of experimental conditions on physiological parameters during phase I studies. Br J Clin Pharmacol 39 (1995) 657-664